The CareVoice Team–Sebastien Gaudin (R2) and Ricky Ng-Adam (R1)
China is undergoing a tremendous transformation over the past two decades, not only economically but also socially and technically. The huge demographic changes are exerting increasing pressures on China’s existing healthcare system that is still under strain.
It seems that more and more people started to recognize the potentials of mHealth as a way to reduce costs of healthcare operations and improve healthcare quality. Investors are voting with massive capital injections in companies related to the sector. The list of such companies to receive funding this year is growing, and includes Chunyu (US$50M in Round C), DXY (US$70M from Tencent), as well as iHealth which just received US$25m from Xiaomi.
Start your free trial now.
Get instant access to all our premium content, archives, newsletters, and online community.
Monthly Membership
Yearly Membership
What you get
Full access to all premium content and our full archives
Members'-only newsletters
Preferential access and discounts to all TechNode events
Direct access to the TechNode newsroom
Start your free trial now.
Get instant access to all our premium content, archives, newsletters, and online community.